| anti-ds DNA (anti-double-stranded deoxyribonucleic acid) | 4.6 IU/mL |
| Medical history | |
| Methodology | CLIA (Chemiluminescence Immuno Assay) |
| anti-SS-A (Ro) | |
| Origin | Germany |
| RF-IgA (Rheumatoid factor IgA) | 5.7 U/mL |
| anti-PR3 (anti-Proteinase 3) | 1.1 U/mL |
| anti-Sm (anti-Smith) | |
| PTH (Parathyroid hormone) | 32.3 pg/mL |
| anti-U1-snRNP (anti-U1 small nuclear ribonucleoprotein) | |
| anti-tTG IgA (anti-Tissue transglutaminase IgA) | 2 RU/mL |
| anti-SS-B (La) | |
| Date of Draw | 2015/6/2 |
| Complement C3 | 1.47 g/L |
| RF-IgG (Rheumatoid factor IgG) | 8.9 U/mL |
| Complement C4 | 0.22 g/L |
| RF-IgM (Rheumatoid factor IgM) | 2.5 IU/mL |
| Manufacturer | IDS-iSYS : IDS Immunodiagnostic Systems |
| anti-MPO (anti-Myeloperoxidase) | 0.5 U/mL |
| Cut_Off_Raw | 30 - 100 |
| Volume | 1 mL |
| beta-CTX / b-CTX (beta-CrossLaps) | 0.36 ng/mL |
| BAP (anti-Bone-specific Alkaline Phosphatase) | 20.5 µg/L |
| CRP | 18.40 mg/L |
| anti-Nucleosome antibodies | 5.9 U/mL |
| CCP (anti-Cyclic citrullinated peptide)/ACPA (anti-Citrullinated protein antibodies) | |
| Clinical diagnosis | Age-related osteoporosis without current pathological fracture, Polymyalgia rheumatica |
| anti-MCV (anti-Mutated citrullinated vimentin) | |
| BGP (Osteocalcin) | 14.4 ng/mL |
| anti-Gliadin IgG | 2 RU/mL |
